Bayer Consumer Health announced Oct. 5 it appointed new general managers to lead its Nutritionals and Digestive Health businesses—two of its fastest growing categories.

After 16 years at Bayer, Lisa Perez is named general manager and vice president marketing – Nutritionals and David Ball has been appointed general manager and vice president marketing – Digestive Health. Perez and Ball will start these new roles on Nov. 1. Both will report directly to Dave Tomasi, chief commercial officer for Consumer Health North America.

“Lisa and David are both exceptional leaders who have delivered significant growth for our business,” Tomasi said in a prepared statement. “Lisa is an inspiring and empowering leader who has led her team through the toughest of times, while David brings a strong set of skills and experiences to his new role, including business leadership, science, and marketing. I look forward to partnering with them both to drive further growth for our Nutritionals and Digestive Health categories.”

Perez currently serves as senior director marketing, Pain/Cardio and has been instrumental in delivering some of the boldest marketing campaigns for Consumer Health, such as the Bayer Aspirin “Your Heart Isn’t Just Your Own” and Bayer Pain “Modern Pains,” which resulted in unprecedented growth and share gains. She was also involved in the successful relaunch of Midol, which resulted in award-winning design, branding and a bold purpose campaign called “Stop Apologizing. Period.”

Most recently, she supported the AleveX launch, which is expected to further accelerate the Aleve turnaround.

In 2005, Perez began her career at Bayer as an assistant customer marketing manager, and since then has advanced to leadership positions in Marketing, working on brands such as One A Day, Alka-Seltzer Plus, and Coppertone.

Ball currently serves as Care/of Retail Go-to-Market lead, responsible for driving the launch of Care/of into retail, developing the go-to market strategies for the retail class of trade, as well as broader marketing and strategy for the company. He successfully launched Care/of into Target, resulting in three product offerings ranking in the top 20 new products for 2021. According to Bayer, in true startup mentality, he owned all facets of the retail proposition including product supply, marketing, sales, media, insights and innovation pipeline development.

Most recently, Ball served as director on the Accelerator team where he led multiple strategies for the division in coordination with Bayer’s Board of Management and Consumer Health Executive Committee, including the Care/of acquisition and the LIFT initiative for North America, which is dedicated to increasing health care access to the underserved.

Before joining Bayer in 2019, he worked at P&G as the commercial leader on multiple iconic over-the-counter brands such as Vicks, Align and Metamucil.